Literature DB >> 14656585

Validation of HPLC and UV spectrophotometric methods for the determination of meropenem in pharmaceutical dosage form.

Andreas S L Mendez1, Martin Steppe, Elfrides E S Schapoval.   

Abstract

A high-performance liquid chromatographic method and a UV spectrophotometric method for the quantitative determination of meropenem, a highly active carbapenem antibiotic, in powder for injection were developed in present work. The parameters linearity, precision, accuracy, specificity, robustness, limit of detection and limit of quantitation were studied according to International Conference on Harmonization guidelines. Chromatography was carried out by reversed-phase technique on an RP-18 column with a mobile phase composed of 30 mM monobasic phosphate buffer and acetonitrile (90:10; v/v), adjusted to pH 3.0 with orthophosphoric acid. The UV spectrophotometric method was performed at 298 nm. The samples were prepared in water and the stability of meropenem in aqueous solution at 4 and 25 degrees C was studied. The results were satisfactory with good stability after 24 h at 4 degrees C. Statistical analysis by Student's t-test showed no significant difference between the results obtained by the two methods. The proposed methods are highly sensitive, precise and accurate and can be used for the reliable quantitation of meropenem in pharmaceutical dosage form.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14656585     DOI: 10.1016/s0731-7085(03)00366-2

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  9 in total

1.  Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patients.

Authors:  Piergiorgio Cojutti; Natalia Maximova; Federico Pea
Journal:  Antimicrob Agents Chemother       Date:  2015-06-29       Impact factor: 5.191

2.  Disposition of ceftobiprole during continuous venous-venous hemodiafiltration (CVVHDF) in a single critically ill patient.

Authors:  Pier Giorgio Cojutti; Maria Merelli; Paola De Stefanis; Cleo Fregonese; Francesca Lucchese; Matteo Bassetti; Federico Pea
Journal:  Eur J Clin Pharmacol       Date:  2018-08-10       Impact factor: 2.953

3.  Dosing nomograms for attaining optimum concentrations of meropenem by continuous infusion in critically ill patients with severe gram-negative infections: a pharmacokinetics/pharmacodynamics-based approach.

Authors:  Federico Pea; Pierluigi Viale; Piergiorgio Cojutti; Mario Furlanut
Journal:  Antimicrob Agents Chemother       Date:  2012-10-08       Impact factor: 5.191

4.  Determination of meropenem in bacterial media by LC-MS/MS.

Authors:  Liusheng Huang; Janus Haagensen; Davide Verotta; Patricia Lizak; Francesca Aweeka; Katherine Yang
Journal:  J Chromatogr B Analyt Technol Biomed Life Sci       Date:  2014-05-14       Impact factor: 3.205

5.  Quercetin in lyotropic liquid crystalline formulations: physical, chemical and functional stability.

Authors:  Fabiana T M C Vicentini; Rúbia Casagrande; Waldiceu A Verri; Sandra R Georgetti; M Vitória L B Bentley; Maria J V Fonseca
Journal:  AAPS PharmSciTech       Date:  2008-05-03       Impact factor: 3.246

Review 6.  How do we use therapeutic drug monitoring to improve outcomes from severe infections in critically ill patients?

Authors:  Gloria Wong; Fekade Bruck Sime; Jeffrey Lipman; Jason A Roberts
Journal:  BMC Infect Dis       Date:  2014-11-28       Impact factor: 3.090

7.  An investigation of the stability of meropenem in elastomeric infusion devices.

Authors:  Finbarr Foy; Giuseppe Luna; Jorge Martinez; Zach Nizich; Jason Seet; Katie Lie; Bruce Sunderland; Petra Czarniak
Journal:  Drug Des Devel Ther       Date:  2019-08-01       Impact factor: 4.162

8.  Real-time TDM-based optimization of continuous-infusion meropenem for improving treatment outcome of febrile neutropenia in oncohaematological patients: results from a prospective, monocentric, interventional study.

Authors:  Pier Giorgio Cojutti; Davide Lazzarotto; Anna Candoni; Maria Vittoria Dubbini; Maria Elena Zannier; Renato Fanin; Federico Pea
Journal:  J Antimicrob Chemother       Date:  2020-10-01       Impact factor: 5.790

9.  Conceptual model of adding antibiotics to dialysate fluid during renal replacement therapy.

Authors:  Ieva Bartuseviciene; Vaidas Vicka; Alvita Vickiene; Lidija Tetianec; Marius Dagys; Donata Ringaitiene; Andrius Klimasauskas; Jurate Sipylaite
Journal:  Sci Rep       Date:  2021-12-13       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.